The Fas counterattack: cancer as a site of immune privilege

Immunol Today. 1999 Jan;20(1):46-52. doi: 10.1016/s0167-5699(98)01382-6.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Apoptosis
  • Fas Ligand Protein
  • Immune Tolerance
  • Immunologic Surveillance
  • Immunotherapy
  • Inflammation
  • Lymphocyte Activation
  • Membrane Glycoproteins / physiology*
  • Models, Immunological
  • Neoplasm Proteins / physiology
  • Neoplasms / immunology*
  • Neoplasms / pathology
  • Polymorphism, Genetic
  • T-Lymphocytes / immunology
  • T-Lymphocytes / pathology
  • fas Receptor / physiology*

Substances

  • Fas Ligand Protein
  • Membrane Glycoproteins
  • Neoplasm Proteins
  • fas Receptor